Oncology

EVAL Foundation

Predicts risk of venous thromboembolism in multiple myeloma

• anticoagulation
• Chemotherapy
• Hematology
• Multiple Myeloma
• Oncology
• Venous Thromboembolism

EVAL Foundation

Evaluates prognosis of systemic mastocytosis

• Hematology
• mastocytosis
• Mayo Alliance Prognostic System (MAPS)
• Oncology
• prognosis
• risk score